American Capital Advisory’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.3K Buy
375
+4
+1% +$495 0.02% 217
2025
Q4
$46.7K Buy
371
+1
+0.3% +$130 0.02% 208
2025
Q3
$54.1K Buy
370
+3
+0.8% +$453 0.03% 184
2025
Q2
$57.2K Buy
367
+3
+0.8% +$476 0.03% 169
2025
Q1
$59.9K Buy
364
+4
+1% +$665 0.03% 161
2024
Q4
$58.7K Hold
360
0.03% 162
2024
Q3
$70.3K Hold
360
0.04% 147
2024
Q2
$71.1K Hold
360
0.05% 130
2024
Q1
$59.9K Hold
360
0.05% 133
2023
Q4
$71.1K Buy
+360
New +$63.7K 0.05% 130

Other funds holding ZTS

American Capital Advisory's ZTS Position: Q1 2026 in Review

American Capital Advisory increased its Zoetis (ZTS) stake by 1.1% in Q1 2026, buying an estimated $495 and bringing the position to 375 shares worth $44.3K. The position accounts for 0.02% of the portfolio, ranked #217.

American Capital Advisory first reported a position in ZTS in Q4 2023 and has held it in 10 quarters since. The position peaked at $71.1K in Q2 2024. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • American Capital Advisory held 375 shares of Zoetis worth $44.3K as of Q1 2026.
  • American Capital Advisory bought 4 Zoetis shares in Q1 2026, an estimated $495.
  • Zoetis made up 0.02% of American Capital Advisory's portfolio in Q1 2026, its #217 holding.
  • American Capital Advisory first reported a position in Zoetis in Q4 2023 and has held it in 10 quarters since.
  • American Capital Advisory's Zoetis position peaked at $71.1K in Q2 2024.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on American Capital Advisory's 13F filing for Q1 2026, filed 29 Apr 2026.